SCRI at Healthone

Denver, Colorado 80218-1238

1 studies enrolling now · 8 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Cancer, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma, Advanced Solid Tumor, CCNE1 Amplification, Cancer, Chondrosarcoma, Chronic Lymphocytic Leukemia, Colorectal Cancer, Endometrial Diseases

Studies at this site

• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — Recruiting now
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor — Recruiting now
• Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors — Running, not enrolling
• A Study of DS-9606a in Patients With Advanced Solid Tumors — Stopped early
• IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma — Running, not enrolling
• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers — Stopped early
• A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors — Completed
• A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors — Stopped early